醫師介紹
醫師學術論文
Paper
學術機構典藏
論文
期刊論文
期刊論文/Journal Paper (作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄) |
日期 | |
1 | 陳彥錩(CHEN, YEN-CHANG)、(Jia-Hong Chen)、(Cheng-Fang Tsai)、(Chen-Yun Wu)、(Chen-Ni Chang)、吳建廷(Chen-Teng Wu)、葉威蘭(Yeh, Wei-Lan)*,Protective effects of paeonol against cognitive impairment in lung diseases,Journal of Pharmacological Sciences,2024 May,155():101-112 | 2024 . 05 |
2 | 陳彥錩(CHEN, YEN-CHANG)、(Jia-Hong Chen)、(Cheng-Fang Tsai)、吳建廷(Chen-Teng Wu)、(Pei-Chun Chang)、葉威蘭(Yeh, Wei-Lan)*,Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers,TOXICOLOGY AND APPLIED PHARMACOLOGY,2024 Feb,483():1-10 | 2024 . 02 |
3 | 蘇孟夏(Meng-Xia Su)、林香汶(Hsiang-Wen Lin)、(Hanh T H Nguyen)、林天照(Tien-Chao Lin)、陳芝蓉(Chih-Jung Chen)、王惠暢(Hwei-Chung Wang)、吳建廷(Chen-Teng Wu)、吳曜充(Yao-Chung Wu)、何庚諺(HE GENG-YAN)、劉良智(Liang-Chih Liu)*、黃至豪(Huang ChihHao)*,Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin,BMC CANCER,2024 Feb,24(1):195 | 2024 . 02 |
4 | (Cheng-Fang Tsai)、陳彥錩(CHEN, YEN-CHANG)、(Ya-Zhen Li)、吳建廷(Chen-Teng Wu)、(Pei-Chun Chang)、葉威蘭(Yeh, Wei-Lan)*,Imperatorin ameliorates pulmonary fibrosis via GDF15 expression,Frontiers in Pharmacology,2023 Dec,14():1292137 | 2023 . 12 |
5 | 林香汶(Hsiang-Wen Lin)、林振源(Chen-Yuan,Lin)、葉子裴(Tzu-Pei Yeh)、林天照(Tien-Chao Lin)、葉婉真(Wan-Chen Yeh)、楊琳鈞(YANG LIN-JUN)、陳育傑(Jack Yu-Chieh Chen)、邱麗螢(Li-Ying Chiu)、吳建廷(Chen-Teng Wu)、陳芝蓉(Chih-Jung Chen)、陳玉芬(Yu-Fen Chen)、王惠暢(Hwei-Chung Wang)、吳曜充(Yao-Chung Wu)、劉良智(Liang-Chih Liu)*,Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time– motion study with mixedmethods research,BMJ Open,2023 Mar,13(3):e059288 | 2023 . 03 |
6 | 陳芝蓉(Chih-Jung Chen)、Nguyen Thi H(Nguyen Thi Hong Hanh)、黃至豪(Huang ChihHao)、王惠暢(Hwei-Chung Wang)、吳建廷(Chen-Teng Wu)、吳曜充(Yao-Chung Wu)、何庚諺(HE GENG-YAN)、(Chiahung Chou)、林香汶(Hsiang-Wen Lin)*、劉良智(Liang-Chih Liu)*,Does the Timing of Eribulin Treatment for Advanced or Metastatic Breast Cancer Matter? Evidence from a Real-World Setting,CHEMOTHERAPY,2023 Jan,68(1):23-34 | 2023 . 01 |
7 | 張芸甄(Chang, Yun-Chen)*、邱昌芳(Chiu, Chang-Fang)*、王治凱(WANG CHIH-KAI)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu),Short-term effect of internet-delivered mindfulness-based stress reduction on mental health, self-efficacy, and body image among women with breast cancer during the COVID-19 pandemic,Frontiers in Psychology,2022 Oct,13():949446 | 2022 . 10 |
8 | 陳彥錩(Chen, Yen-Chang)、吳建廷(Chen-Teng Wu)、(Jia-Hong Chen)、(Cheng-Fang Tsai)、巫宸昀(Wu, Chen-Yun)、(Pei-Chun Chang)、葉威蘭(Yeh, Wei-Lan)*,Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition,Oncogenesis,2022 Aug,11(1):48 | 2022 . 08 |
9 | 陳彥錩(Chen, Yen-Chang)、(Jia-Hong Chen)、(Cheng-Fang Tsai)、吳建廷(Chen-Teng Wu)、(Miao-Hsiang Wu)、(Pei-Chun Chang)、葉威蘭(Yeh, Wei-Lan)*,Nicardipine Inhibits Breast Cancer Migration via Nrf2/HO-1 Axis and Matrix Metalloproteinase-9 Regulation,Frontiers in Pharmacology,2021 Aug,12():710978 | 2021 . 08 |
10 | (Cheng-Fang Tsai)、(Jia-Hong Chen)、吳建廷(Chen-Teng Wu)、(Pei-Chun Chang)、(Shu-Lin Wang)、葉威蘭(Yeh, Wei-Lan)*,Induction of osteoclast-like cell formation by leptin-induced soluble intercellular adhesion molecule secreted from cancer cells,Therapeutic Advances in Medical Oncology,2019 May,11():1-20 | 2019 . 05 |
研討會論文
研討會論文/Conference Papers (發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目) |
日期 | |
1 | E.B.M (Evident, Beauty, Motivation) breast reconstruction: using a modified dual plane with bra-flap supporting in direct to implant to achieving safe and promising result,台灣整形外科醫學會第21屆會員大會暨學術研討會,台北南港展覽館2館,2022.12.17~2022.12.18, | 2022 . 12 |
專書
暫無資料研究計畫
研究計畫/Research Grant (研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,計畫期間) |
日期 | |
1 | 個別型,DMR-112-036,葉威蘭(Yeh, Wei-Lan),本校(含附醫),探討癌細胞之細胞程式死亡受體與配體的調控之接觸依賴性,2022.8.1~2023.7.31 | 2022 . 08 |
2 | 個別型,DMR-110-047,葉威蘭(Yeh, Wei-Lan),附醫院內計畫,探討地爾硫䓬在癌症的治療:生長分化因子15的角色,2020.8.1~2021.7.31 | 2020 . 08 |
3 | 個別型,CMU109-ASIA-14,吳建廷(Chen-Teng Wu)、張培均,本校(含附醫),L-type鈣離子通道阻斷劑對腫瘤轉移之影響及治療方針之開發,2020.8.1~2021.7.31 | 2020 . 08 |
4 | 個別型,DMR-109-036,葉威蘭(Yeh, Wei-Lan),附醫院內計畫,鈣離子通道阻斷劑調控基質金屬蛋白酶在乳癌的應用,2019.8.1~2020.7.31 | 2019 . 08 |
5 | 產學合作,10742680,劉良智(Liang-Chih Liu)、陳育傑(Yu-Chieh Chen)、吳建廷(Chen-Teng Wu)、陳芝蓉(Chih-Jung Chen)、吳曜充(Yao-Chung Wu)、葉子裴(Tzu-Pei Yeh),羅氏藥廠,表皮生長因子2陽性之早期乳癌病人接受靜脈或皮下Trastuzumab施打對其醫療資源使用及自述成效的影響-時間動作研究,2018.11.28~2019.12.31 | 2018 . 11 |
6 | 個別型,A1051222-107,邱昌芳(Chang-Fang Chiu)、蔡銘修(Ming-Hsui Tsai)、陳自諒(Tzu-Liang Chen)、柯道維(Tao-Wei Ke)、王輝明(Hwei-Ming Wang)、陳宏彰(Hung-Chang Chen)、黃郁純(Yu-Chuen Huang)、花俊宏(Chun-Hung Hua)、張兆祥(Chao-Hsiang Chang)、楊啟瑞(Chi-Rei Yang)、吳錫金(Hsi-Chin Wu)、黃志平(Chi-Ping Huang)、蔡宗欣(Tzong-Shin Tzai)、張議徽(Yi-Huei Chang)、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、吳建廷(Chen-Teng Wu)、劉良智(Liang-Chih Liu)、吳曜充(Yao-Chung Wu)、陳芝蓉(Chih-Jung Chen)、鄭書(Yu-Shu Cheng)、方信元(Hsin-Yuan Fang)、夏德椿(Te-Chun Hsia)、李嘉翔(Chia-Hsiang Li)、陳鴻仁(Hung-Jen Chen)、劉秋松(Chiu-Shong Liu)、陳毓隆(Yu-Lung Chen)、王中儀(JONG-YI WANG),衛福部,全方位癌症照護醫病共享決策輔助工具介入及其效益評估(106-107年) 107年後續擴充,2018.10.5~2019.10.4 | 2018 . 10 |
7 | 個別型,DMR-108-160,葉威蘭(Yeh, Wei-Lan),附醫院內計畫,探討分泌型黏著蛋白在癌細胞的分子和功能性角色,2018.8.1~2019.6.30 | 2018 . 08 |